NASDAQ
HAVN Life Sciences Inc. (HAVLF) has a price/sales ratio of 29.84x as of Friday, May 22, 2026. The price-to-sales ratio evaluates a company's stock price relative to its revenue, useful for valuing companies with little or no earnings.
No price data available for this timeframe.